Knee osteoarthritis (OA) is a common condition affecting millions worldwide. Symptoms like pain and reduced mobility impact daily life. A study highlighted that around 37% of adults aged 60 and older have knee OA, showcasing the widespread nature of this joint disease.

In recent years, various viscosupplementation treatments have been developed to alleviate symptoms, including Durolane and Euflexxa. Durolane contains hyaluronic acid, which helps lubricate the knee joint, while Euflexxa is also a hyaluronic acid product designed to mimic the natural fluid found in joints. Both aim to reduce pain and improve joint function but differ in formulation and longevity.

This article will explore the differences between Durolane and Euflexxa and evaluate which treatment may be more effective for managing knee OA symptoms.

Key Takeaways

  • Durolane and Euflexxa inject hyaluronic acid into the joint to treat knee osteoarthritis, but they work differently. Durolane requires one shot, while Euflexxa requires three shots over three weeks.
  • People using Durolane report less pain and better movement that can last up to six months with just one injection. Euflexxa users also feel improvement, which may extend up to a year after completing all injections.
  • The cost of treatment varies; a single Durolane injection costs between $500 and $800, whereas Euflexxa’s complete treatment totals around $600-$900. Choosing between them depends on factors like how long relief lasts and cost-effectiveness.
  • Both treatments have mild side effects, like joint pain or swelling at the injection site. Serious problems are rare, making both options safe for most patients.
  • Experts suggest weighing factors such as duration of relief, safety profiles, patient satisfaction, and costs when deciding between Durolane and Euflexxa for effectively managing knee OA symptoms.

About: Medical Spa RX provides medical practices with premium products at the best prices. If you’re looking to buy Durolane wholesale for your practice, the sales representatives at Medical Spa RX can give you guidance.

Introduction to Durolane and Euflexxa

Knee treatment.

Osteoarthritis (OA) is a prevalent joint condition causing pain and stiffness, often impacting the knees, hips, hands, and spine. This degenerative disease gradually erodes joint cartilage, leading to discomfort and limited mobility.

Viscosupplements, such as Durolane and Euflexxa, play a crucial role in treating knee osteoarthritis. These treatments involve injecting hyaluronic acid directly into the knee joint to enhance lubrication and cushioning. Durolane requires just one injection, while Euflexxa necessitates three weekly shots. Durolane contains 20mg/ml of hyaluronic acid, whereas Euflexxa’s syringe holds 2ml.

Comparing Durolane and Euflexxa is essential, given that 54.4 million adults in the U.S. suffer from osteoarthritis, with up to 41% of cases involving the knee joint. Finding effective treatments remains a priority.

Composition and Mechanism of Action

Knee treatment.
  • Durolane: This viscosupplement contains non-animal stabilized hyaluronic acid (NASHA), a high-purity form of hyaluronic acid. This HA is crosslinked, creating a gel that provides long-lasting lubrication and cushioning in the joint. When injected, Durolane supplements the synovial fluid, which is often depleted in osteoarthritis, enhancing joint mobility and reducing pain.
  • Euflexxa: This injection is a bioengineered hyaluronic acid (HA) designed to closely resemble the natural HA found in human synovial fluid. It increases the synovial fluid’s viscosity and elasticity, providing better lubrication and shock absorption within the joint. Euflexxa’s composition improves joint function and pain relief over multiple injections.

Clinical Efficacy and Safety Profiles

Knee treatment.

Recent evidence suggests that Durolane effectively reduces pain and improves functionality in patients with OA of the knee. However, guidelines neither explicitly recommend nor discourage its use, indicating variability in the existing evidence base. Durolane has a favorable safety profile, with mild, local, and transient adverse events.

Similarly, Euflexxa, which also contains sodium hyaluronate, demonstrates positive clinical outcomes in OA patients. Its natural origin and biocompatibility contribute to its effectiveness. Euflexxa shares a common safety profile with other HA-based viscosupplements, with minimal and localized adverse events.

Specific Benefits and Duration of Relief

When choosing viscosupplementation treatments for osteoarthritis (OA), it is crucial to understand the specific benefits and duration of relief offered by different products like comparing Durolane vs Monovisc, Hyalgan, or Synvisc. Both Durolane and Euflexxa provide significant pain relief and improved joint function, but their protocols and durations of efficacy vary. 

Durolane’s Benefits and Duration of Relief

  • Pain Reduction: Durolane effectively reduces joint pain, allowing patients to engage in daily activities with greater comfort.
  • Improved Functionality: By enhancing joint lubrication and cushioning, Durolane improves knee function and mobility.
  • Minimal Side Effects: Adverse events associated with Durolane are generally mild, local, and transient.
  • Duration of Relief: The duration of pain relief varies but typically lasts several months, necessitating repeat injections as needed.

Euflexxa’s Benefits and Duration of Relief

  • Pain Alleviation: Euflexxa effectively reduces knee pain, enhancing patients’ quality of life.
  • Natural Origin: Derived from hyaluronic acid, Euflexxa is biocompatible and well-tolerated.
  • Duration of Relief: Similar to Durolane, Euflexxa’s pain relief typically lasts several months and requires periodic injections.

Treatment Protocols and Patient Satisfaction

Durolane is typically administered as a single intra-articular injection. Repeat injections can be given after several months if needed. It is suitable for patients with mild to moderate OA symptoms and is commonly used in knee OA, although it may also be applicable to other joints.

On the other hand, Euflexxa is administered as a series of three weekly injections. After several months, patients may require additional cycles. Euflexxa is appropriate for mild to moderate OA and is primarily used in knee OA.

Patient satisfaction varies for both treatments. Some individuals experience significant pain relief and improved function with Durolane. Similarly, patient satisfaction is positive for Euflexxa, especially when combined with appropriate physical therapy and lifestyle modifications.

Cost Comparison

The cost of Durolane injections can vary significantly based on factors such as location, healthcare provider, and insurance coverage. Generally, Durolane is priced higher than some other viscosupplements. Despite its higher price, Durolane offers specific benefits, including pain reduction and improved joint function. Patients who prioritize these advantages may find the investment worthwhile.

Patients considering Durolane should consult their healthcare provider to obtain accurate pricing information. Some insurance plans may cover part of the cost, but verifying this beforehand is essential.

Euflexxa is typically more cost-effective compared to Durolane. Its relative affordability makes it an attractive option for patients seeking OA pain relief without breaking the bank. The exact cost of Euflexxa injections can still vary, but it is approximately 20% cheaper than some other HA-based viscosupplements. 

Patients should discuss Euflexxa’s cost with their healthcare provider and explore any available insurance coverage or assistance programs.

Expert Reviews and Recommendations

Durolane goes beyond solely alleviating pain. It also aids individuals in moving with more ease and achieving greater satisfaction from their lives post-treatment. This is due to the unique treatment characteristic: it requires just a one-time administration, and its efficacy is prolonged.

Experts have mixed feelings about Euflexxa. Some say it works well for knee osteoarthritis. They point out that Euflexxa comes from bacteria but in a good way. This means it’s made through bacterial fermentation, which is neat.

On the other hand, not all experts are sold on Euflexxa. Some studies have indeed shown that Euflexxa’s benefits may not significantly differ from placebos, highlighting the need for cautious consideration when choosing Euflexxa for patients with knee pain.

Conclusion

Choosing between Durolane and Euflexxa for osteoarthritis treatment can be challenging. Both have their perks. Durolane needs just one shot and can ease the pain for up to six months. Euflexxa needs three shots, which might help for a year sometimes.

Both have few and mild side effects. So, talking with a medical professional is key to finding what works best for your knee pain relief journey.

FAQs

1. What are Durolane and Euflexxa?

Durolane and Euflexxa are treatments for Osteoarthritis (OA). They’re used to relieve joint pain and improve mobility.

2. How do Durolane and Euflexxa work in treating OA?

Both Durolane and Euflexxa work by replacing or supplementing the natural fluids in your joints, helping reduce friction, decrease inflammation, and enhance movement.

3. Are there any differences between Durolane and Euflexxa?

While both aim to treat OA symptoms, they may differ in their formulation, dosage frequency, and side effects profile. It’s crucial to consult a healthcare professional for personalized advice.

4. Which is better – Durolane or Euflexxa?

It depends on individual patient needs. Factors like age, severity of symptoms, and response to previous treatments play a part. It’s best discussed with your doctor, who can make an informed decision based on these considerations.

schedule a meeting with sales representative MedicalSpaRX
Need help or additional information?

Our sales representatives are here for you!

SCHEDULE A MEETING

References

Dillon, C. F., Rasch, E. K., Gu, Q., & Hirsch, R. (2006). Prevalence of knee osteoarthritis in the United States: Arthritis data from the Third National Health and Nutrition Examination Survey 1991-94. The Journal of Rheumatology, 33(11), 2271-2279. https://www.jrheum.org/content/33/11/2271.long

Gomoll, A. H., Filardo, G., Espregueira-Mendes, J., Madry, H., & Nakamura, N. (2021). A comprehensive review of viscosupplementation in osteoarthritis of the knee. Orthopedic Reviews, 13(3), 25549. https://orthopedicreviews.openmedicalpublishing.org/article/25549-a-comprehensive-review-of-viscosupplementation-in-osteoarthritis-of-the-knee

OGOMED. (n.d.). Comparing Durolane and Euflexxa injections: Which is the better choice? OGOMED. Retrieved July 26, 2024, from https://ogomed.com/comparing-durolane-and-euflexxa-injections-which-is-the-better-choice/